cardium therapeutics inc (CRXM:OTC US)
Robert L. Engler M.D.
Chief Medical Advisor and Consultant, TaxuCardium Pharmaceuticals Group Inc.
|Age||Total Calculated Compensation||This person is connected to 48 board members in 4 different organizations across 5 different industries.|
See Board Relationships
Dr. Robert L. Engler, M.D. has been Chief Medical Advisor of Cardium Therapeutics Inc.., since November 29, 2005 and serves as its Consultant. Dr. Engler is a Cardiovascular Consultant of Angel Investor. He serves as a Scientific Advisor of Surgery & Heart Failure at PeriCor Therapeutics, Inc. He served as Vice President and Medical Director of Collateral Therapeutics from 1995 to 1998. He was Professor of Medicine at UCSD in Cardiology from 1975 to 2001, Associate Chief ...
11750 Sorrento Valley RoadPhone: 858-436-1000
San Diego, California 92121
Board Members Memberships*
Scientific Advisor of Surgery & Heart Failure and Director
Independent Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
University of North Carolina
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|